CRDL

Cardiol Therapeutics Inc.

2.97 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cardiol Therapeutics Inc. stock is up 36.24% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 June’s closed higher than May. 100% of analysts rate it a buy.

About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD) Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability.

  • HC Wainwright & Co.
    Fri Jun 7, 06:59
    buy
    confirm
  • Canaccord Genuity
    Thu May 23, 07:57
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 14, 10:56
    buy
    confirm